The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report - 2021; Focus on recipient characteristics.

No abstract is available for this paper.

• Publication year

  2021

• Venue

  The Journal of Heart and Lung Transplantation

• Publication date

  2021-07-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.healun.2021.07.015PMID 34419370PMCID PMC10282986
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy.

  2021cited by this paper
• A change of heart: Preliminary results of the US 2018 adult heart allocation revision

  2020cited by this paper
• Impact of continuous flow left ventricular assist device therapy on chronic kidney disease: a longitudinal multicenter study.

  2020cited by this paper
• The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics.

  2020cited by this paper
• Recipient Age Impacts Long-Term Survival in Adult Cystic Fibrosis Subjects after Lung Transplantation.

  2020cited by this paper
• Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes.

  2020cited by this paper
• Mortality trends around the one‐year survival mark after heart, liver, and lung transplantation in the United States

  2020cited by this paper
• Time for reform in transplant program–specific reporting: AST/ASTS transplant metrics taskforce

  2019cited by this paper
• The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match.

  2019cited by this paper
• Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation.

  2019cited by this paper
• Survival Outcomes After Heart Transplantation: Does Recipient Sex Matter?

  2019cited by this paper
• Improved HLA typing of Class I and Class II alleles from next‐generation sequencing data

  2019cited by this paper
• The Impact of Sex on Alloimmunity.

  2018cited by this paper
• The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report-2018; Focus Theme: Multiorgan Transplantation.

  2018cited by this paper
• Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation.

  2017cited by this paper
• Predicted heart mass is the optimal metric for size match in heart transplantation.

  2017cited by this paper
• Desensitization: Overcoming the Immunologic Barriers to Transplantation

  2017cited by this paper
• The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time.

  2017cited by this paper
• Sex Related Differences in the Risk of Antibody-Mediated Rejection and Subsequent Allograft Vasculopathy Post-Heart Transplantation: A Single-Center Experience

  2016cited by this paper
• Cardiac size and sex-matching in heart transplantation : size matters in matters of sex and the heart.

  2014cited by this paper
• Children and young adults with CF in the USA have better lung function compared with the UK

  2014cited by this paper
• Influence of donor and recipient sex mismatch on heart transplant outcomes: analysis of the International Society for Heart and Lung Transplantation Registry.

  2012cited by this paper
• Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: implications for donor allocation.

  2010cited by this paper
• The epidemiology of obesity.

  2010cited by this paper
• The influence of donor gender on allograft vasculopathy: evidence from intravascular ultrasound.

  2004cited by this paper
• Cardiac allograft vasculopathy after heart transplantation: risk factors and management.

  2004cited by this paper
• Sirolimus in De Novo Heart Transplant Recipients Reduces Acute Rejection and Prevents Coronary Artery Disease at 2 Years: A Randomized Clinical Trial

  2004cited by this paper
• Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.

  2003cited by this paper
• The role of nonimmune risk factors in the development and progression of graft arteriosclerosis: preliminary insights from a multicenter intravascular ultrasound study. Multicenter Intravascular Ultrasound Transplant Study Group.

  1995cited by this paper
• Effect of pravastatin on outcomes after cardiac transplantation.

  1995cited by this paper
• Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors.

  1994cited by this paper

• Heart Transplantation: Focus on Rejection and the Rare Complication of Eosinophilic Myocarditis

  2026cites this paper
• Risk Factors for Primary Graft Dysfunction after Heart Transplantation - a Systematic Review and Meta-Analysis

  2026cites this paper
• Cardiopulmonary exercise test criteria for heart transplantation referral of patients with ambulatory heart failure in the current era

  2026cites this paper
• Empagliflozin Supplementation in Cardioplegic Solution Improves Donor Heart Preservation by Maintaining Mitochondrial Homeostasis.

  2026cites this paper
• Paediatric Heart Transplantation in Resource-Limited Settings: A Silent Crisis.

  2026cites this paper
• MECKI score thresholds for heart transplantation referral of ambulatory heart failure patients.

  2026cites this paper
• When the Target Is Not the Driver: Rethinking LDL in Cardiac Allograft Vasculopathy.

  2026cites this paper
• Association of Longitudinal High-Sensitivity Cardiac Troponin T With Clinical Outcomes in Adult Heart-Transplant Recipients.

  2026cites this paper
• Effectiveness Study of Bundle Maintenance Strategies in Donor Lung Quality Improvement.

  2026cites this paper
• The Father of Heart Transplantation History Forgot: Vladimir P. Demikhov, MD (1916-1998).

  2026cites this paper
• Deep Learning in Cardiovascular Tissue Engineering: A Review on Current Advances and Future Perspectives

  2026cites this paper
• Cumulative weight–based rabbit antithymocyte globulin dosing for induction in heart transplantation: Impact on outcomes

  2025cites this paper
• Corticosteroid use beyond 1-year post heart transplantation is associated with worse outcomes: A contemporary analysis of the ISHLT registry

  2025cites this paper
• Caspase-3 in Brain Death Donors Is Associated with Reduced Primary Graft Dysfunction After Heart Transplantation

  2025cites this paper
• A step closer to the holy grail? The utility of extracorporeal photopheresis in lung transplantation

  2025cites this paper
• Immunosuppression Management in Heart Transplantation

  2025cites this paper
• Extracorporeal Photopheresis in the Treatment of Cardiac Allograft Rejection in the Modern Era: A Single‐Center Experience

  2025cites this paper
• Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes

  2025cites this paper
• Role of Computed Tomography and Other Non-Invasive and Invasive Imaging Modalities in Cardiac Allograft Vasculopathy

  2025cites this paper
• Rehabilitation in children with ventricular assist devices

  2025cites this paper
• Transforming heart transplantation care with multi-omics insights

  2025cites this paper
• Invasive Fungal Infections in Orthotopic Heart Transplant Patients: Incidence and Risk Factors in the Modern Era

  2025cites this paper
• Ultrasound-targeted microbubble destruction: a prospective strategy for treating cardiovascular disease

  2025cites this paper
• Association of Cardiovascular Biomarkers With Cardiac Allograft Vasculopathy and Atherosclerotic Coronary Artery Disease

  2025cites this paper
• Percutaneous Assessment and Intervention of Outflow Graft Stenosis in Left Ventricular Assist Device Patients-A Cohort Study.

  2025cites this paper
• Tissue-resident CCR2+ macrophage TREM-1/3 signaling is necessary for monocyte and neutrophil recruitment to injured hearts

  2025cites this paper
• Primary Graft Dysfunction in Patients Supported With Durable Left Ventricular Assist Devices Before Heart Transplantation.

  2025cites this paper
• PET/CT with Myocardial Blood Flow Assessment Is Prognostic of Cardiac Allograft Vasculopathy Progression and Clinical Outcomes

  2025cites this paper
• History and Recent Advances in Heart Transplantation: A Narrative Review

  2025cites this paper
• Selection Patterns and Outcomes of Kidney Transplantation Versus Dialysis in Lung Recipients with End-Stage Renal Disease: A Single-Center Retrospective-Observational Study

  2025influential citation
• Ten‐Year Pediatric Heart Transplantation: Insights and Outcomes From a Leading Center in Iran

  2025cites this paper
• Société de Biomécanique Young Investigator Award: In silico study of the effects of Left Ventricular Assist Device inflow cannula design and pump unsteady flow on left ventricular hemodynamics.

  2025cites this paper
• CCR2-targeted nanoparticles combined with sonodynamic therapy attenuates the acute rejection of heart transplants.

  2025cites this paper
• Health-related Quality of Life and Exercise Capacity in Double Lung Transplant Recipients With Baseline Lung Allograft Dysfunction

  2025cites this paper
• Advancement of Heart Transplantation in Thai Recipients: Survival Trends and Pharmacogenetic Insights

  2025cites this paper
• Cardiac MRI in Heart Transplantation: Approaches and Clinical Insights.

  2025cites this paper
• The burden of skin cancer in heart transplant recipients: Impact of immunosuppressive regimens

  2025cites this paper
• Risk Estimation of Severe Primary Graft Dysfunction in Heart Transplant Recipients Using a Smartphone

  2025cites this paper
• Pregnancy After Solid Organ Transplantation: Review of the Evidence and Recommendations.

  2025cites this paper
• Warm-ischemia and Cold Storage Induced Modulation of Ferroptosis Observed in Human Hearts Donated After Circulatory Death and Brain Death.

  2025cites this paper
• Disparities in Heart Transplantation Allocation and Outcomes by Blood Type in Korea (2010–2022)

  2025cites this paper
• Outcomes in patients with chronic heart failure undergoing non‐cardiac surgery: a secondary analysis of the METREPAIR international cohort study*

  2025cites this paper
• Gender in post-cardiac transplant patients has no effect on the occurrence of death, major cardiovascular events or development of cardiac allograft vasculopathy.

  2025cites this paper
• International Experience of Donation After Circulatory Death for Lung Transplantation. A Special Report from the International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation.

  2025cites this paper
• Time Well Spent: Clinical Predictors of Days Alive and Out of the Hospital After Heart Transplantation

  2025cites this paper
• Sacubitril suppresses experimental chronic heart allograft vasculopathy.

  2025cites this paper
• Renal Recovery after Heart Transplantation in Patients With Type 1 Cardiorenal Syndrome Requiring Dialysis: Insights From a Cohort Without Mechanical Circulatory Support

  2025cites this paper
• Recent progress of nanomaterials for diagnosis and treatment of rejection in heart transplantation

  2025cites this paper
• Optimizing outcomes in heart transplantation: multidisciplinary Heart Teams and mechanical circulatory support for primary graft dysfunction

  2025cites this paper
• The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 2025 Annual Report of Heart and Lung Transplantation.

  2025cites this paper
• New Techniques for the Optimization of Donor Lungs/Hearts.

  2025cites this paper
• Exploring the Potential of Voxel-Mirrored Homotopic Connectivity (VMHC) and Regional Homogeneity (ReHo) in Understanding Cognitive Changes After Heart Transplantation

  2025cites this paper
• Severe Primary Graft Dysfunction of the Transplanted Heart - More Than a Single Category?

  2025cites this paper
• REGIONAL DIFFERENCES IN PRIMARY GRAFT DYSFUNCTION: A REPORT FROM THE INTERNATIONAL CONSORTIUM ON PGD.

  2025cites this paper
• Long-term prognosis after orthotopic heart transplantation

  2025cites this paper
• Cardiac Allograft Vasculopathy in the Era of Precision Medicine: The Role of Biomarkers and Advanced Imaging.

  2025cites this paper
• Impact and Outcomes After Desensitization Therapy in Highly Sensitized Heart Transplant Candidates.

  2025cites this paper
• Multicenter study for CH-VAD as a fully magnetically levitated left ventricular assist device

  2025cites this paper
• Barriers to Immunosuppressant Medication Adherence in Thoracic Transplant Recipients: Initial Findings

  2025cites this paper
• Surveillance donor-specific antibody and pathologic antibody-mediated rejection testing in heart transplant patients in the contemporary era

  2025cites this paper
• Adult heart transplantation in the USA and Western Europe: state of the art review.

  2025cites this paper
• Diabetes is an Increasingly Common Issue After Heart Transplantation: A Case for Integrated Diabetes Care.

  2025cites this paper
• Textual Annotation in the Prediction of Heart and Lung Transplantation Outcomes from Donor Data*

  2025cites this paper
• Case Report: Cardiac transplantation in a 76-year-old recipient: moving from anagraphic to biological age under a geriatric perspective

  2025cites this paper
• From the Bench to the Bedside and Back: Contemporary Applications of Basic Science to Innovations in Heart Transplantation.

  2025cites this paper
• 7Improved 2-year Heart Transplant Survival with Moderate Hypothermic Donor Heart Preservation in the GUARDIAN Heart Registry.

  2025cites this paper
• A population-based analysis of immunosuppression therapy after organ transplantation

  2025cites this paper
• RBM25 Regulates p38 MAPK Pathway Activation via Exon 16 Skipping of MAP4K4 in a Rat Model of Post‐Infarction Heart Failure

  2025cites this paper
• Treatment of advanced heart failure

  2024cites this paper
• Comparative Analysis of Ischemia‐Reperfusion Injury in Heart Transplantation: A Single‐Center Study Evaluating Conventional Ice‐Cold Storage versus the Paragonix SherpaPak Cardiac Transport System

  2024cites this paper
• Prognostic Value of APACHE IV Score in Patients Bridged to Heart Transplantation on ECMO

  2024cites this paper
• Donation After Circulatory Death Heart Transplant: Current State and Future Directions.

  2024cites this paper
• Impact of institutional variables on center performance in long-term survival after heart transplant.

  2024cites this paper
• Cardio‐Renal‐Metabolic Outcomes Associated With the Use of GLP‐1 Receptor Agonists After Heart Transplantation

  2024cites this paper
• 日本における重症心不全外科治療の進捗

  2024cites this paper
• Correlation Between Tacrolimus Levels in Blood Samples Obtained From Central Catheter and Peripheral Venipuncture in Lung Transplant Patients (Ven-Cat Study)

  2024cites this paper
• Unmet need for heart transplantation in Africa

  2024cites this paper
• Pathology of explanted pediatric hearts: An 11‐year study. Population characteristics and implications for outcomes

  2024cites this paper
• How to Use Nuclear Cardiology to Evaluate Cardiac Allograft Vasculopathy.

  2024cites this paper
• Examining a 12-year experience within Kazakhstan’s national heart transplantation program

  2024cites this paper
• CAV Trajectories Among Patients With No or Mild CAV at 10 Years Posttransplant

  2024cites this paper
• Early Outcomes in Patients With LVAD Undergoing Heart Transplant via Use of the SherpaPak Cardiac Transport System

  2024cites this paper
• The Association between Pre-operative Pectoralis Muscle Quantity and Outcomes after Cardiac Transplantation.

  2024cites this paper
• The Potential for Heart Donation After Death Determination by Circulatory Criteria in the Province of Québec

  2024cites this paper
• Impact of new allocation policy on waitlist and transplant outcomes of adult congenital heart patients supported with ECMO.

  2024cites this paper
• Emergency Department Use and Hospital Mortality Among Heart Transplant Recipients in the United States

  2024cites this paper
• Advanced Heart Failure Therapies in The Eastern Mediterranean Region: Current Status, Challenges, and Future Directions.

  2024cites this paper
• The Utility of the Vasoactive-Inotropic Score and Its Nomogram in Guiding Postoperative Management in Heart Transplant Recipients

  2024cites this paper
• CD47 blockade reduces ischemia/reperfusion injury in murine heart transplantation and improves donor heart preservation.

  2024cites this paper
• "Durable Left Ventricular Assist Devices as a Bridge to Transplantation in The Old and The New World".

  2024cites this paper
• Cardiopulmonary transplantation

  2024cites this paper
• A Radiographic Score for Human Donor Lungs on Ex Vivo Lung Perfusion Predicts Transplant Outcomes.

  2024cites this paper
• Usage of Older Donors is Associated with Higher Mortality After Heart Transplantation: A UNOS Observational Study.

  2024cites this paper
• 3D Printing for Left Ventricular Assist Device Exchange

  2024cites this paper
• Benefit And Risk Of Endomyocardial Biopsy For Heart Transplant Patients In The Contemporary Era

  2024cites this paper
• Cardiac allograft vasculopathy outcomes among donation after circulatory death heart transplant recipients

  2024cites this paper
• Can Grading of Mild Cardiac Allograft Vasculopathy be Further Refined? An angiographic and physiologic assessment of heart transplant recipients with ISHLT CAV 1.

  2024cites this paper
• The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10–12 Years After Heart Transplantation: The Results of a Randomized Controlled Trial (SCHEDULE Trial)

  2024cites this paper
• Donor pulmonary hemodynamics does not impact recipient outcomes in adult heart transplantation.

  2024cites this paper
• Elevated Donor-Derived Cell-Free DNA Levels Are Associated With Reduced Myocardial Blood Flow but Not Angiographic Cardiac Allograft Vasculopathy: The EVIDENT Study

  2024cites this paper